News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cellerant Therapeutics, Inc. Announces Key Additions to Sr. Management Team


2/7/2011 8:07:06 AM

SAN CARLOS, Calif.--(BUSINESS WIRE)--Cellerant Therapeutics Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, announced that it has strengthened its senior management team with the appointments of Margaret Dillon, Ph.D., as Vice President of Regulatory Affairs and Robert Tressler, Ph.D., as Vice President of Research & Development.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES